Merck Teams Up With Sinopharm On Vaccines As It Gears Up For Gardasil Approval In China
This article was originally published in The Pink Sheet Daily
Executive Summary
Sinopharm is the largest China-owned pharma and is operated by an agency of the central government in Beijing.
You may also be interested in...
U.S. Merck Looks For Developing Country Markets
Merck's second-quarter results demonstrate the risks and rewards of becoming less U.S.-centric. Emerging markets expansion and new product launches outside of the U.S. drove growth, but EU price cuts dampened revenues and profits.
Southeast Asian Regulators Ramp Up Anti-Corruption, Bribery Enforcement Ahead of ASEAN Pact
Regulators in Southeast Asia are working to tighten bribery and corruption enforcement as part of a broader push ahead of an Association of Southeast Asian Nations trade pact in 2015 for greater transparency in pharmaceuticals.